BILL & MELINDA GATES FOUNDATION
GHDDI is the foundation's first foray into founding such an institute globally. The success of this institute will play an important part in winning the fight against infectious diseases that disproportionately affect the poorest in developing countries.
Co-Chair of the Bill & Melinda Gates Foundation
The establishment of GHDDI is an important effort by Tsinghua University to advance pharmaceutical research and translational medicine. I hope this initiative will facilitate the reform of pharmaceutical R&D system in China and impact global health.
CPC SECRETARY OF TSINGHUA UNIVERSITY
BEIJING MUNICIPAL GOVERNMENT
Over the past few years, the Global Health Drug Discovery Institute (GHDDI) has witnessed significant progress and remarkable achievements in leveraging artificial intelligence technology to drive innovative drug development and facilitate the practical implementation of outcomes. These advancements have made valuable contributions to both the development of Beijing and global health initiatives. We express our aspirations for continued collaboration and strengthened partnership between the Bill and Melinda Gates Foundation and Beijing, aiming to further enhance the growth and advancement of GHDDI.
MAYOR OF BEIJING
- Gates Foundation Renews Collaboration With Beijing Government and Tsinghua University on Innovative Therapies for Infectious Diseases Prevalent in Low- and Middle-Income Countries 2023/06/15
- GHDDI Announces Advancement of a Novel Oral Antiviral Candidate for COVID-19 in Its Investigational New Drug Studies 2022/01/25
- 2021 Annual Letter | The Year, Global Health Went Local 2021/01/27
FOCUS ON INNOVATION AND DELIVERABLES
GHDDI has been striving to develop new drugs that address global disease challenges. We have made groundbreaking achievements in antiviral, anti-TB, and anti-malaria with a number of projects entered clinical trials.LEARN MORE
GHDDI is dedicated to creating a comprehensive and interconnected industry chain for new drug research and development on a global scale. This goal is achieved through the establishment of collaborations with over 40 of the world's top scientific research institutes, pharmaceutical and biotechnology companies, technology enterprises, and disease alliances across different fields.JOIN US